Medical and Pharmaceutical New York doctor warns that change in fingernails can be linked to lung cancer He says anyone who notices it, even without other symptoms, should seek medical attention Rowan DunneAugust 7, 2025
Medical and Pharmaceutical Giant inflatable lungs help promote cancer detection in United Kingdom They will make an appearance to help celebrate the Cambridge debut of a national screening program Rowan DunneAugust 5, 2025
Medical and Pharmaceutical Hong Kong lung cancer survivor advocates for AI-powered screening measures Artificial intelligence has the power to cut healthcare costs associated with lung cancer screening in half, he highlighted Rowan DunneJuly 28, 2025
Medical and Pharmaceutical Lung cancer survivor & spouse use wood ribbons to promote disease awareness The White Ribbon Project aims to draw attention to how anyone can be diagnosed with the condition Rowan DunneJuly 24, 2025
Medical and Pharmaceutical bioAffinity Technologies obtains Canadian patent for lung cancer spit test The CyPath Lung screening tool is also patented in China, Australia and Japan Rowan DunneJuly 22, 2025
Medical and Pharmaceutical Medpace Holdings stock just popped by 50%, but why? Medpace delivered a standout Q2, with revenue rising 14.2 per cent year-over-year to USD$603.3 million Joseph MortonJuly 22, 2025
Health & Wellness Oxford Biodynamics surges after Pfizer trial backs blood-based cancer test The platform makes it possible to track disease progression and therapy effectiveness in real-time Joseph MortonJuly 18, 2025
Medical and Pharmaceutical American researcher anticipates robust growth for e-nose market Market.US is one of multiple that believe the breath analysis industry will be expanding significantly Rowan DunneJuly 17, 2025
Health & Wellness BeOne Medicines gets positive stock bump on RBC Capital upgrade Analysts see strong upside potential in BeOne’s move into solid tumours Joseph MortonJuly 16, 2025
Medical and Pharmaceutical Cizzle Bio submits NIH grant proposal for biomarker blood test for lung cancer The study will analyze pre-diagnostic and longitudinal blood plasma samples from the PLCO Cancer Screening Trial Joseph MortonJuly 14, 2025